An inconsistent boom-and-bust cycle funding environment for early-stage biotech innovations and burdensome regulation ...

Any project, supported or not by a committee, that is currently being worked on or is considered active, and will have an end date. This series of meetings of experts, organized under the auspices of ...

Michael Schultz is director of venture operations at Portal Innovations, where he is always looking for innovations that could revolutionize the life sciences. "We work with many startups, and all of ...

China and the U.S. are in a race for preeminence in biotechnology. The U.S. is still dominant in biology and life sciences research, but China is catching up fast. At the same time, Congress and the ...

The opening session sets the context and intent for the Inaugural Summit: USA-Saudi Biotech Alliance, outlining the strategic ...

Presentation will showcase Company's patented iSPERSE™ technology and positive topline results from Phase 1 study of PUR3100 for acute migraine Pulmatrix plans to submit an IND in mid-2023 for a ...

WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, developer of the leading AI foundation model for tumor and immune biology, today announced it has been named “Overall Immunology Company of the Year” in ...

SACRAMENTO – Today, (Aug. 19) Theresa Maldonado, the University of California’s Vice President for Research and Innovation, will provide testimony at an informational hearing on the impact of federal ...

Editor's note: This article was updated at 1030a with comments from President Trump at a morning news conference and a statement from the Biotechnology Innovation Association. It was further updated ...

Dallas, Texas - The Andrew Hillman Grant for Biotech is now open for applications, marking a significant academic opportunity for undergraduate students across the United States who are committed to ...